Bleeding Events Before vs After Lowering Departmental Platelet Transfusion Trigger

Launched by THOMAS KANDER · Dec 17, 2023

Keywords

ClinConnect Summary

**Clinical Trial Summary: Lowering Platelet Transfusion Triggers for Central Venous Catheters**

This clinical trial is investigating whether it is safe to reduce the number of platelets required before placing a central venous catheter (a tube inserted into a large vein to give treatment) in patients with low platelet counts. Platelets are important for blood clotting, and patients with certain blood disorders often have lower counts, which increases their risk of bleeding. The study aims to compare bleeding events after lowering the platelet transfusion trigger from 50,000 to just 10,000 platelets per cubic millimeter. Researchers want to ensure that this change does not lead to severe bleeding complications.

To be eligible for this trial, participants must be 18 years or older and need a central venous catheter for treatment in a hematology ward. The study is currently recruiting participants who meet these criteria. Those who join can expect to undergo monitoring for bleeding events after their catheter is placed. This research is important because it could help improve the safety and effectiveness of care for patients with low platelet counts. If you or a loved one are considering participation, it’s a great opportunity to contribute to important medical research.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • ≥ 18 years of age
• • Indication for central venous catheter placement.
• • Patients admitted to a hematological ward at the current department
• Exclusion Criteria:
• • Death within 24h after insertion of CVC.